BWXT Subsidiary Awarded $122 Million Contract Extension for Uranium Downblending Services February 14, 2024
BWX Technologies to Announce Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27 January 18, 2024
BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology November 16, 2023
BWXT Selected as Nuclear Fuel and Component Manufacturer for Air Force Research Laboratory’s JETSON Program November 8, 2023
